Polymorphism atposition-308of TNFagene influences response to infliximab therapy in rheumatoid arthritis.

被引：0
|
作者：
Mugnier, B [1 ]
Reviron, D [1 ]
Balandraud, N [1 ]
Roudier, C [1 ]
Roudier, J [1 ]
机构：
[1] INSERM, EMI 9940, F-13258 Marseille, France
来源：
ARTHRITIS AND RHEUMATISM | 2003年 / 48卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
225
引用
收藏
页码：S129 / S129
页数：1
相关论文
共 50 条
  • [1] Polymorphism in the TNF promoter gene (-308A) correlates with worse response to infliximab in rheumatoid arthritis.
    Pinto, JA
    Mosquera, A
    Freire, M
    Rego, I
    Lopez-Armada, MJ
    Maneiro, E
    Galdo, F
    Fernández-García, JL
    Blanco, FJ
    [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S399 - S399
  • [2] Polymorphism at the position -308 of TNF-α gene influences outcome of infliximab therapy in rheumatoid arthritis
    Mugnier, B
    Reviron, D
    Darque, A
    Balandraud, N
    Roudier, C
    Roudier, J
    [J]. ARTHRITIS RESEARCH & THERAPY, 2004, 6 (Suppl 1) : S23 - S24
  • [3] Polymorphism at position-308 of TNFalfa gene influences outcome of infliximab therapy in rheumatoid arthritis
    Mugnierl, B
    Balandraud, N
    Roudier, C
    Roudier, J
    Reviron, D
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 190 - 190
  • [4] Polymorphism at the position -308 of TNF-α gene influences outcome of infliximab therapy in rheumatoid arthritis
    B Mugnier
    D Reviron
    A Darque
    N Balandraud
    C Roudier
    J Roudier
    [J]. Arthritis Res Ther, 6
  • [5] Polymorphism at position-308 of the promoter of the tumor necrosis factor α gene and infliximab therapy in rheumatoid arthritis.
    Fonseca, JE
    Carvalho, T
    Cruz, M
    Nero, P
    Sobral, M
    Mourao, AF
    Cavaleiro, J
    Carmo-Fonseca, M
    Branco, J
    [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S394 - S394
  • [6] Polymorphism at position-308 of the tumor necrosis factor a gene influences outcome of infliximab therapy in rheumatoid arthritis
    Mugnier, B
    Balandraud, N
    Darque, A
    Roudier, C
    Roudier, J
    Reviron, D
    [J]. ARTHRITIS AND RHEUMATISM, 2003, 48 (07): : 1849 - 1852
  • [7] Infliximab in rheumatoid arthritis.
    Moreland L.
    [J]. Current Rheumatology Reports, 2004, 6 (5) : 334 - 335
  • [8] Polymorphism in the TNF promoter gene (-308A) correlates with worse response to infliximab in rheumatoid arthritis
    Pinto, JA
    Mosquera, A
    Fernandez-García, JL
    Freire, M
    De Toro, FJ
    Maneiro, E
    Lopez-Armada, MJ
    Galdo, F
    Blanco-García, F
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 305 - 305
  • [9] -308 A/G polymorphism in the tumor necrosis factor-α gene influences outcome of etanercept treatment in rheumatoid arthritis.
    Guis, Sandrine, Sr.
    Balandraud, Nathalie
    Bouvenot, Julien
    Auger, Isabelle
    Mugnier, Benedicte
    Toussirot, Eric
    Wendling, Daniel
    Mattei, Jean Pierre
    Tomachot, Benoit
    Legeron, Pierre
    Landt, Olfert
    Roudier, Jean
    Roudier, Chantal
    [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S231 - S231
  • [10] Cost effectiveness of infliximab in rheumatoid arthritis.
    Kavanaugh, A
    Patel, KK
    Bala, M
    Noe, L
    [J]. ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S144 - S144
12345